The Fundingsland Group and its education host, the John A. Moran Eye Center at the University of Utah, are proud to launch an inaugural Masterclass on targeting the complement pathway in patients with age-related macular degeneration (AMD) and geographic atrophy (GA), including the use of FDA-approved therapies. This exclusive initiative is designed for early-career retina specialists and fellows aiming to lead the future of geographic atrophy (GA) care secondary to age-related macular degeneration (AMD), and help learners implement best practices for integrating complement therapy treatments, improving patient education and compliance, and managing patient flow and reimbursement structures.

The 30-hour Masterclass will accommodate 30 learners participating in the following exclusive activities led by some of the top retinal surgeons in the United States

• Mentor-guided didactic modules.
• Mentor-led interactive live webinars to review the latest literature and answer all questions.
• Knowledge exchange with mentors and peers.
• In-person case review grand rounds at the Moran Eye Center on March 20 and 21, 2026.
• In-person wet labs, workshops, and professional development activities at the Moran Eye Center in March 20-21, 2026.

• Access to ongoing Webinars 12 months post-program

The GA Masterclass aims to improve practice patterns and clinical outcomes and significantly grow the number of patients treated in the field of retinal disease.

The application deadline is December 15, 2025.

The Geographic Atrophy Masterclass aims to offer comprehensive didactic and hands-on training to early-career retina fellows to improve retinal care and reduce the disease’s burden in our communities.

This Masterclass program will include the following:

Each learner is assigned a mentor to support questions and advise throughout the program. Participants will be part of a small WhatsApp group with direct access to their mentor.

Learners will participate in four online modules. Each module accounts for approximately 2 hours of content from leading experts.

• The Pathogenesis of GA
• Multi-Modal Diagnostic Strategies for Early Diagnosis and Monitoring
• Safety, Efficacy, and Outcomes Data
• Best Practices for Clinic Flow and Reimbursement Structure

Mentor-led, interactive webinars with all mentors and learners to summarize the module, review relevant literature, and answer any questions.

Learners will participate in a structured journal club discussion led by mentors and focusing on critically analyzing key studies related to dry AMD and GA, evaluating clinical trial data, and discussing real-world application of research findings.

Learners will gain deeper insights into the evidence supporting complement therapy while honing their ability to assess literature and apply data to clinical decision-making.

In-person half-day case review grand rounds in Salt Lake City on March 20 and 21, 2026 (attendance required).

In-person wet labs in Salt Lake City at the Moran Eye Center on March 20 and 21, 2026, including hands-on experience with injection techniques.
(Attendance required)

Each participant who completes these components and passes an exam will obtain a certificate of completion signed by the program director and mentors. 

A special certificate of commendation will be given to the top 20% of exam scores.

This Masterclass is primarily targeted toward retinal specialists who:

• Are current retina fellows, recent fellow graduates, and retina specialists within the first 5 years of practice.
• Manage more than 250 retina patients per year.
• ECP interested in learning about anti-complement therapies for GA, due to AMD
• Have begun using complement therapy or intend to start immediately following the educational program.
• Are based in a US surgical facility where complement therapy is available.

Learners agree to complete all online course modules and attend the in-person case review, wet labs, workshops, and exam in Salt Lake City on March 20-21, 2026.

Program organizers will cover the cost of hotel accommodations for the nights of March 19 and March 20, as learners will need to travel to the location on March 19. All program meals on March 20 and March 21 will also be provided. All other travel costs will be the learner’s responsibility. 

Travel Scholarships are available.

• Applications are submitted through the Masterclass Application and should include a detailed CV.
• Applications are reviewed by the Masterclass Mentors.
• Priority will be given to surgeons who best fit the targeted learner criteria identified above.
• The application deadline is December 15, 2025.

Click on name to read bio

Click on name to read bio

The John A. Moran Eye Center serves as the Department of Ophthalmology and Visual Sciences at the University of Utah School of Medicine.

It is the largest ophthalmology clinical care and research facility in the Mountain West, with more than 60 faculty members and 10 satellite clinics.

Physicians provide comprehensive care in all ophthalmic subspecialties, making the Moran Eye Center a major referral center for complex cases, with over 150,000 patient visits and about 8,000 surgeries annually.

Moran supports 20 basic and translational research labs and centers, including the Alan S. Crandall Center for Glaucoma Innovation, directed by Iqbal Ike K. Ahmed, MD, FRCSC.

U.S. News & World Report consistently ranks Moran among the Top 10 Best Hospitals for Ophthalmology and Doximity ranks its residency program among the Top 10 nationwide.

Moran CEO and Department of Ophthalmology and Visual Sciences Chair Randall J Olson, MD, leads more than 700 employees working to achieve Moran’s vision that no person with a blinding condition, eye disease, or visual impairment should be without hope, understanding, and treatment. To increase access to care locally and in underserved countries worldwide, Moran runs the largest global outreach program of its kind at any U.S. academic institution.

The Fundingsland Group (TFG) is an independent medical education company that believes in providing compelling, compliant, and effective peer-to-peer education that addresses gaps in clinical knowledge, opinions, and practice patterns. Through a unique, data-driven process, TFG identifies key educational needs and evaluates progress towards meeting clearly defined goals. By strategically collaborating with education partners and industry experts, we create customized education programs that seek to change opinions, affect practice patterns and, ultimately, improve patient care. 

Copyright © 2025 The Fundingsland Group. All rights reserved.